Approval · Notice of Compliance 13658 · 2012
AVENTICARP CAPLETS: Notice of Compliance 13658
Issued September 19, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13658
- Date
- September 19, 2012
- Company
- Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Alternate brand name
- Therapeutic class
- Non-steroidal Anti-inflammatory
- Canadian reference product
- RIMADYL CAPLETS (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVENTICARP CAPLETS | 02393409 | Cancelled Post Market |
| AVENTICARP CAPLETS | 02393417 | Cancelled Post Market |
| AVENTICARP CAPLETS | 02393425 | Cancelled Post Market |